Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a …
Background People who inject drugs are exposed to various and changing risk
environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed …
environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed …
[HTML][HTML] The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …
the face of European hepatology is changing due to the cure of viral hepatitis C and the …
[HTML][HTML] Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023
Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality.
Although treatment is not considered curative, antiviral treatment, monitoring, and liver …
Although treatment is not considered curative, antiviral treatment, monitoring, and liver …
Health disparities in chronic liver disease
The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to
important changes in liver disease epidemiology that have exacerbated health disparities …
important changes in liver disease epidemiology that have exacerbated health disparities …
EASL recommendations on treatment of hepatitis C: final update of the series☆
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage …
Background Sharing of equipment used for injecting drug use (IDU) is a substantial cause of
disease burden and a contributor to blood-borne virus transmission. We did a global …
disease burden and a contributor to blood-borne virus transmission. We did a global …
[HTML][HTML] Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices
S Schillie - MMWR. Recommendations and reports, 2018 - cdc.gov
Hepatitis B virus (HBV) is transmitted via blood or sexual contact. Persons with chronic HBV
infection are at increased risk for cirrhosis and liver cancer and require medical care. This …
infection are at increased risk for cirrhosis and liver cancer and require medical care. This …
Update on global epidemiology of viral hepatitis and preventive strategies
Viral hepatitis is one of the major public health concerns around the world but until recently it
has drawn little attention or funding from global health policymakers. Every year 1.4 million …
has drawn little attention or funding from global health policymakers. Every year 1.4 million …
Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection
Background Hepatitis delta virus (HDV) coinfects with hepatitis B virus (HBV) causing the
most severe form of viral hepatitis. However, its exact global disease burden remains largely …
most severe form of viral hepatitis. However, its exact global disease burden remains largely …
Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 …
Objective China concentrates a large part of the global burden of HBV infection, playing a
pivotal role in achieving the WHO 2030 global hepatitis elimination target. Methods We …
pivotal role in achieving the WHO 2030 global hepatitis elimination target. Methods We …